Reebok Nano X1 Cross Training Shoes

Marsoni

M251S

$129.99

Get it in 3 business days with 1 day shipping. Friday, May 29

Reebok Nano X1 Cross Training ShoesReebok Nano X1 Crossfit Shoes Climb, jump and throw the barbell around in shoes made for the way you work out. Perfected by elite athletes, Reebok Nano X1 Shoes are made for anyone who loves to train hard. This men's version has a Flexweave knit upper that's breathable yet durable, with integrated support for multidirectional movement. Floatride Energy Foam cushioning in the forefoot provides a responsive feel. A heel clip adds stability. Features

Easy Shipping

Quick Dispatch:

Your Reebok Nano X1 Cross Training Shoes orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Reebok Nano X1 Cross Training Shoes ships.

Need Help?
Questions about Reebok Nano X1 Cross Training Shoes, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Reebok Nano X1 Cross Training Shoes in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

This is a super cute, and frankly, fairly high fashion little hoodie. The price was great for what it is. Really nice soft (terry?) inside. Double fabric hood. Really soft. It has an oversized cut which makes it easy to get on and off, but is just the right length to make the sizing look great and intentional - it doesn't look too big. I love the color. It's high quality, and I didn't notice any shrinkage. Even the hood is cut in a chic way. Not your average kids' hoodie.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on October 26, 2025